Development of a consensus molecular classifier for pancreatic ductal adenocarcinoma

We developed a robust consensus classifier for PDAC that integrates tumor and stroma features. The classifier is accessible through the R package PDACMOC (PDACMolecularOmniClassifier, https://github.com/pavillos/PDACMOC , https://doi.org/10.5281/zenodo.17161373 ) and a Shiny app ( https://pdacmoc.cnio.es/ ). This classifier offers a biologically grounded framework that integrates existing systems, allows for single-sample classification, and improves prognostic stratification. By enabling subtype-specific therapies and better patient stratification in clinical trials, it can help guide precision medicine and enhance outcomes in PDAC management.

Authors

Institutions

Publication Details

Journal
Genome Medicine
Published
2025-11-14
DOI
https://doi.org/10.1186/s13073-025-01568-9
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of a consensus molecular classifier for pancreatic ductal adenocarcinoma

Evangelina López de Maturana, Pablo Villoslada-Blanco, Sergio Sabroso‐Lasa, Lola Alonso et al.
Genome Medicine
Pancreatic and Hepatic Oncology Research
article

Development of a consensus molecular classifier for pancreatic ductal adenocarcinoma

Evangelina López de Maturana, Pablo Villoslada-Blanco, Sergio Sabroso‐Lasa, Lola Alonso, Lidia Estudillo, Francisco X. Real, Núria Malats, Miguel Maquedano
article en

Abstract

We developed a robust consensus classifier for PDAC that integrates tumor and stroma features. The classifier is accessible through the R package PDACMOC (PDACMolecularOmniClassifier, https://github.com/pavillos/PDACMOC , https://doi.org/10.5281/zenodo.17161373 ) and a Shiny app ( https://pdacmoc.cnio.es/ ). This classifier offers a biologically grounded framework that integrates existing systems, allows for single-sample classification, and improves prognostic stratification. By enabling subtype-specific therapies and better patient stratification in clinical trials, it can help guide precision medicine and enhance outcomes in PDAC management.

Genome MedicineVol. 17(1)
Spanish National Cancer Research Centre (ES)
Stand Up To Cancer, Instituto de Salud Carlos III, FP7 Health
Openalex Percentile: Top 53%
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.